Literature DB >> 28599575

Suppression of miR-34a Expression in the Myocardium Protects Against Ischemia-Reperfusion Injury Through SIRT1 Protective Pathway.

Bi-Cheng Fu1,2, Ji-Lu Lang1,2, Dong-Yang Zhang1,2, Lu Sun1,2, Wei Chen1,2, Wei Liu2, Kai-Yu Liu1,2, Chong-Yi Ma1,2, Shu-Lin Jiang1,2, Ren-Ke Li3,4, Hai Tian1,2.   

Abstract

MicroRNA-34a (miR-34a) is expressed in the myocardium and expression is altered after myocardial injury. We investigated the effects of miR-34a on heart function after ischemia-reperfusion (IR) injury. Cardiomyocytes were isolated from neonatal rat hearts and simulated IR injury was induced in vitro. Following IR injury in rats, infarct size was measured and left ventricular (LV) function was evaluated using echocardiography. Protein expression of silent information regulator 1 (SIRT1), acetylated p53 (ac-p53), Bcl-2 and Bax, and miR-34a and SIRT1 gene levels were analyzed. miR-34a overexpression exacerbated myocardial injury by increasing apoptosis and infarct size and decreasing LV function. Suppression of miR-34a attenuated myocardial IR injury. SIRT1 was negatively regulated by miR-34a and the expression of downstream genes, such as ac-p53, Bcl-2, and Bax were altered correspondingly. Increased expression of miR-34a aggravates injury after IR; miR-34a suppression therapy may represent a new line of treatment for myocardial IR injury.

Entities:  

Keywords:  SIRT1; apoptosis; cardiomyocytes; ischemia–reperfusion injury; microRNA-34a

Mesh:

Substances:

Year:  2017        PMID: 28599575     DOI: 10.1089/scd.2017.0062

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  14 in total

Review 1.  Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

Authors:  Roopesh S Gangwar; Sanjay Rajagopalan; Rama Natarajan; Jeffrey A Deiuliis
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

2.  Circular RNA circDENND2A protects H9c2 cells from oxygen glucose deprivation-induced apoptosis through sponging microRNA-34a.

Authors:  Yuanxia Shao; Peng Zhong; Li Sheng; Hongjian Zheng
Journal:  Cell Cycle       Date:  2019-12-27       Impact factor: 4.534

Review 3.  MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes.

Authors:  Hassan Dehaini; Hussein Awada; Ahmed El-Yazbi; Fouad A Zouein; Khodr Issa; Assaad A Eid; Maryam Ibrahim; Adnan Badran; Elias Baydoun; Gianfranco Pintus; Ali H Eid
Journal:  Cells       Date:  2019-02-12       Impact factor: 6.600

4.  MiR-138-5p exacerbates hypoxia/reperfusion-induced heart injury through the inactivation of SIRT1-PGC-1α.

Authors:  Cuiping Wang; Xia Sun; Zhi Qiu; Anyong Chen
Journal:  Inflamm Res       Date:  2019-07-16       Impact factor: 4.575

5.  MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism.

Authors:  Hai-Feng Zhang; Yi-Cheng Wang; Yi-Di Han
Journal:  Mol Med Rep       Date:  2018-01-09       Impact factor: 2.952

6.  miR‑27a suppresses TLR4‑induced renal ischemia‑reperfusion injury.

Authors:  Yang Wang; Dan Wang; Zhen Jin
Journal:  Mol Med Rep       Date:  2019-06-04       Impact factor: 2.952

7.  Rno-microRNA-30c-5p promotes myocardial ischemia reperfusion injury in rats through activating NF-κB pathway and targeting SIRT1.

Authors:  Jianfeng Chen; Mingming Zhang; Shouyan Zhang; Junlong Wu; Shufeng Xue
Journal:  BMC Cardiovasc Disord       Date:  2020-05-20       Impact factor: 2.298

8.  Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a.

Authors:  Fengyun Zhang; Kun Wang; Fei Gao; Yongli Xuan; Xiaohong Liu; Zhuoqi Zhang
Journal:  Front Pharmacol       Date:  2021-04-20       Impact factor: 5.810

Review 9.  Deciphering Non-coding RNAs in Cardiovascular Health and Disease.

Authors:  Anindita Das; Arun Samidurai; Fadi N Salloum
Journal:  Front Cardiovasc Med       Date:  2018-07-02

10.  USP22 Protects Against Myocardial Ischemia-Reperfusion Injury via the SIRT1-p53/SLC7A11-Dependent Inhibition of Ferroptosis-Induced Cardiomyocyte Death.

Authors:  Shuxian Ma; Linyan Sun; Wenhao Wu; Jiangli Wu; Zhangnan Sun; Jianjun Ren
Journal:  Front Physiol       Date:  2020-10-21       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.